Effect of 3g Versus 2 g MMF in Combination With Tacrolimus on Progression of Renal Allograft Interstitial Fibrosis

PHASE4CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

June 30, 2016

Study Completion Date

June 1, 2016

Conditions
Kidney TransplantationKidney Failure
Interventions
DRUG

Mycophenolate mofetil

Mycophenolate will be administered to all study patients at dose of 3 g daily for the first seven days posttransplant. Afterwards, study patients will continue, as randomized, on either 3 g, or 2 g MMF daily.

Trial Locations (1)

10000

Clinical Hospital Merkur, Zagreb

All Listed Sponsors
lead

Clinical Hospital Merkur

OTHER

collaborator

University Medical Centre Ljubljana

OTHER

collaborator

University Hospital Rijeka

OTHER

NCT01860183 - Effect of 3g Versus 2 g MMF in Combination With Tacrolimus on Progression of Renal Allograft Interstitial Fibrosis | Biotech Hunter | Biotech Hunter